TMO: who owns it, and who’s predicted to buy next
Thermo Fisher Scientific Inc · Industrials · on the Prior Moves forward board for 2026-06-30 at rank #15. Research, not investment advice.
Predicted to buy next quarter
16 tracked investors are predicted to hold or add TMO as a position for 2026-06-30, each by that investor’s own walk-forward model. This is a statement about a filing pattern, about six weeks ahead of the public 13F, never a claim that anyone has bought it or that you should.
- David Abrams · Abrams Capital
- Bill Ackman · Pershing Square
- Lee Ainslie · Maverick
- Chuck Akre · Akre Capital
- Brad Gerstner · Altimeter
- Ariel
- Ray Dalio · Bridgewater
- Warren Buffett · Berkshire Hathaway
- Michael Burry · Scion
- Philippe Laffont · Coatue
- Corvex
- Stanley Druckenmiller · Duquesne
- Egerton
- David Einhorn · Greenlight
- Engaged
- Bruce Berkowitz · Fairholme
Highest model probability: Dan Sundheim at 92%.
Currently disclosed holders
From the most recent 13F books we track, 3 investors disclose a position in TMO (weight = share of that investor’s US equity book). A 13F can be up to 45 days stale.
| Investor | Book weight |
|---|---|
| Dan Sundheim · D1 Capital | 3.2% |
| Larry Robbins · Glenview | 3.1% |
| Andreas Halvorsen · Viking Global | 2.3% |
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.
See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-06-30, data as of 2026-07-18. Research, not investment advice, see the disclaimer.